🇺🇸 FDA
Patent

US 8697046

Methods of administering interferon gamma to absorb fluid from the subretinal space

granted A61KA61K38/217A61K9/0048

Quick answer

US patent 8697046 (Methods of administering interferon gamma to absorb fluid from the subretinal space) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K38/217, A61K9/0048, A61P, A61P27/02